Back to top
more

Astrana Health, Inc. (ASTH)

(Real Time Quote from BATS)

$39.04 USD

39.04
113,962

+0.15 (0.39%)

Updated May 13, 2024 04:00 PM ET

After-Market: $39.18 +0.14 (0.36%) 4:16 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (68 out of 251)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for ASTH

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Astrana Health, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 296 294 287 261 220
Receivables 148 124 90 61 76
Notes Receivable 0 3 4 0 23
Inventories 0 0 0 0 0
Other Current Assets 17 15 19 17 10
Total Current Assets 462 435 399 339 329
Net Property & Equipment 7 109 53 30 12
Investments & Advances 32 41 43 80 29
Other Non-Current Assets 26 0 1 5 0
Deferred Charges 0 0 0 0 0
Intangibles 350 353 336 326 342
Deposits & Other Assets 18 6 6 19 2
Total Assets 933 964 852 817 729
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 60 50 44 36 27
Current Portion Long-Term Debt 20 1 1 11 10
Current Portion Capital Leases 1 1 0 0 0
Accrued Expenses 107 84 56 50 59
Income Taxes Payable 0 0 1 4 5
Other Current Liabilities 27 9 11 10 2
Total Current Liabilities 219 147 115 115 105
Mortgages 0 0 0 0 0
Deferred Taxes/Income 4 3 9 11 18
Convertible Debt 0 0 0 0 0
Long-Term Debt 259 203 183 230 232
Non-Current Capital Leases 1 1 1 0 0
Other Non-Current Liabilities 4 20 15 0 0
Minority Interest (Liabilities) -206 14 56 114 169
Total Liabilities 317 409 392 487 536
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 371 360 311 261 160
Retained Earnings 243 193 144 70 32
Other Equity 2 2 6 0 1
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 617 555 460 331 192
Total Liabilities & Shareholder's Equity 933 964 852 817 729
Total Common Equity 617 555 460 331 192
Shares Outstanding 58.20 56.70 55.50 54.20 34.80
Book Value Per Share 10.60 9.79 8.30 6.11 5.53

Fiscal Year End for Astrana Health, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents 337 296 277 298 279
Receivables 184 148 184 151 156
Notes Receivable 0 0 1 1 1
Inventories 0 0 0 0 0
Other Current Assets 17 17 14 15 22
Total Current Assets 539 462 476 465 458
Net Property & Equipment 8 7 129 124 113
Investments & Advances 42 32 47 49 44
Other Non-Current Assets 47 26 25 0 0
Deferred Charges 0 0 0 0 0
Intangibles 530 350 350 348 354
Deposits & Other Assets 21 18 25 23 5
Total Assets 1,226 933 1,073 1,027 993
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable 0 0 0 0 0
Accounts Payable 146 60 53 50 49
Current Portion Long-Term Debt 21 20 3 3 1
Current Portion Capital Leases 1 1 1 1 1
Accrued Expenses 136 107 98 100 101
Income Taxes Payable 6 0 30 20 0
Other Current Liabilities 40 27 15 9 10
Total Current Liabilities 355 219 203 186 165
Mortgages 0 0 0 0 0
Deferred Taxes/Income 4 4 12 12 4
Convertible Debt 0 0 0 0 0
Long-Term Debt 368 259 206 205 205
Non-Current Capital Leases 1 1 1 1 1
Other Non-Current Liabilities 8 14 21 22
Minority Interest (Liabilities) -206 -206 18 14 15
Total Liabilities 568 317 476 457 429
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 395 371 363 357 353
Retained Earnings 258 243 231 209 207
Other Equity 4 2 4 4 3
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 658 617 598 570 563
Total Liabilities & Shareholder's Equity 1,226 933 1,073 1,027 993
Total Common Equity 658 617 598 570 563
Shares Outstanding 56.00 58.20 57.50 57.50 57.40
Book Value Per Share 11.75 10.60 10.39 9.91 9.81